DISCOVERY OF THE DECADE
To celebrate our participating companies’ leadership in identifying this decade as one of history’s most productive for research, the Committee will select three products – a pharmaceutical drug, a biotech drug and a medical or diagnostic technology – as the “Discovery of the Decade.”
The three awards will be featured as a special highlight to the next annual ceremony at the American Museum of Natural History in New York on Thursday, October 27, 2016.
Nomination for these three awards is applicable to every medicine and medical technology that the Committee selected as the category winner in our previous annual honors since 2007 – 34 in all, including the 2016 Prix Galien USA Laureates. Each winning product has contributed to an unsurpassed record of clinical advances that embody the Galien Foundation’s mission to improve the state of global health.
We will cite the company winners for their leadership in innovative drug and technology development during the evening ceremony program in conjunction with the 2016 Prix Galien USA, which will include prominent leaders in health care as well as commentary from members of the Awards Committee. As you know, the Committee is an independent body of biomedical scientists and key opinion leaders in the field of medicine which includes four Nobel Laureates. Our choices are made solely on the basis of the best medical evidence without bias.
With my best personal regards,
P. Roy Vagelos, M.D
Chairman of the USA Galien Awards Committee